This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pinheiro, S. P. Articles by Michels, K. B. Search for Related Content PubMed PubMed Citation Articles by Pinheiro, S. P. Articles by Michels, K. B.

A Prospective Study on Habitual Duration of Sleep and Incidence of Breast Cancer in a Large Cohort of Women

¹ Department of Epidemiology, Harvard School of Public Health; ² Channing Laboratory, Departments of Medicine and ³ Ostetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; and ⁴ LBI-ACR VIEnna and ACR-IRT VIEnna, Vienna, Austria

Requests for reprints: Simone P. Pinheiro, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-623-3371; E-mail: simone.pinheiro{at}chaning.harvard.edu.

Mounting evidence suggests habitual sleep duration is associated with various health outcomes; both short and long sleep duration have been implicated in increased risk of cardiovascular disease, diabetes, and all-cause mortality. However, data on the relation between sleep duration and cancer risk are sparse and inconclusive. A link between low levels of melatonin, a hormone closely related to sleep, and increased risk of breast cancer has recently been suggested but it is unclear whether duration of sleep may affect breast cancer risk. We explored the association between habitual sleep duration reported in 1986 and subsequent risk of breast cancer in the Nurses' Health Study using Cox proportional hazards models. During 16 years of follow-up, 4,223 incident cases of breast cancer occurred among 77,418 women in this cohort. Compared with women sleeping 7 hours, covariate-adjusted hazard ratios and 95% confidence intervals for those sleeping 5, 6, 8, and 9 hours were 0.93 (0.79-1.09), 0.98 (0.91-1.06), 1.05 (0.97-1.13), and 0.95 (0.82-1.11), respectively. A moderate trend in risk increase towards longer sleep duration was observed when analyses were restricted to participants who reported same sleep duration in 1986 and 2000 (P_trend = 0.05). In this prospective study, we found no convincing evidence for an association between sleep duration and the incidence of breast cancer. (Cancer Res 2006; 66(10): 5521-25)

This article has been cited by other articles:

				R. G Stevens Light-at-night, circadian disruption and breast cancer: assessment of existing evidence Int. J. Epidemiol., August 1, 2009; 38(4): 963 - 970. [Abstract] [Full Text] [PDF]

				V. Srinivasan, D W. Spence, S. R. Pandi-Perumal, I. Trakht, and D. P. Cardinali Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms Integr Cancer Ther, September 1, 2008; 7(3): 189 - 203. [Abstract] [PDF]

				A. H. Wu, R. Wang, W.-P. Koh, F. Z. Stanczyk, H.-P. Lee, and M. C. Yu Sleep duration, melatonin and breast cancer among Chinese women in Singapore Carcinogenesis, June 1, 2008; 29(6): 1244 - 1248. [Abstract] [Full Text] [PDF]